Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

KFC Hall

Dec 15, 2017 9:30 AM - Dec 15, 2017 6:30 PM

1-6-1 Yokoami, Sumida-ku, Tokyo, 130-0015 Japan

2nd DIA Cell Therapy Products Symposium in Japan


Click Here to View the Program

Member fees will be applied to members of Forum for Innovative Regenerative Medicine (FIRM) as well as to DIA members. Please send the application form to DIA Japan office by fax or e-mail.

2nd DIA Cell Therapy Products Symposium in Japan
- End to End Development and Implementation: Steady Progress by Industry, Academia, and Government in Practical Use

The development of regenerative medicine in Japan, accelerated by new regulatory and legal systems that began to be scaled into practical use in 2013, has attracted considerable international attention. Currently, research has progressed to the point that many cell therapy products, both inside and outside Japan, are now entering clinical development, and this, in turn, has revealed a number of issues in product development, distribution, and post-marketing.

DIA Japan held its first Cell Therapy Products Symposium last year to bring together stakeholders, particularly from industry and academia, who were involved in developing cell therapy products. The mission was to share insights and exchange ideas with relevant government authorities in order to deepen mutual understanding and resolve issues of concern.

This year, the second Cell Therapy Products Symposium will focus on specific issues and challenges from the beginning of product development to post-marketing of domestic and overseas products, offering a platform for sharing experience and problem-solving efforts by leaders in academia and industry. Overseas trends and combination products with medical devices will be also reviewed. We hope for lively discussions on resolving these issues, and also on charting a direction for future development and business strategies that will be well harmonized internationally.

The DIA Cell Therapy Product Symposium encourages ongoing discussion across industry, academia, and government. We hope that this symposium will continue to grow as a place for sharing knowledge and insights about the latest product developments and as a highly valued networking opportunity for all participants. We look forward to your active participation.


Want to learn more about 2nd DIA Cell Therapy Products Symposium in Japan? You've come to the right site!


Who should attend?

Cell therapy product development professionals in pharmaceuticals, medical devices companies, venture companies, or academia

Program Committee

  • Yoji  Sato, PhD
    Yoji Sato, PhD Head, Division of Drugs
    National Institute of Health Sciences, Japan
  • Yasuko  Terao, PhD
    Yasuko Terao, PhD Head, External Scientific Engagement, R&D Japan Region,
    Takeda Pharmaceutical Co., Ltd., Japan
  • Teruyo  Arato, PhD
    Teruyo Arato, PhD Professor, Clinical Research and Medical Innovation Center
    Hokkaido University Hospital, Japan
  • Masaki  Kasai, PhD
    Masaki Kasai, PhD Reviewer, Office of Cellular and Tissue-based Products,
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Keiji  Miyamoto
    Keiji Miyamoto Principal Post-Marketing Regulatory Affairs Dep.
    Daiichi Sankyo Co.,Ltd., Japan
  • Sosuke  Miyoshi, PhD
    Sosuke Miyoshi, PhD
    Astellas Pharma Inc., Japan
  • Hiromi  Okabe, PhD
    Hiromi Okabe, PhD Immunology, Regulatory Affairs Japan,Global Drug Development Division
    Novartis Pharma K.K, Japan
  • Hideki  Onimatsu, PhD
    Hideki Onimatsu, PhD Manager, Regulatory CMC, Regulatory Affairs Department
    Takeda Pharmaceutical Company Limited, Japan
  • Kazuhiro  Takekita
    Kazuhiro Takekita Instructor, Department of Cardiovascular Surgery, Graduate School of Medicine,
    Osaka University, Japan
  • Kouichi  Tsuji
    Kouichi Tsuji General Manager, Clinical Development Department
    Terumo Corporation, Japan
  • Yoshie  Tsurumaki
    Yoshie Tsurumaki Group Manager, Cell & Gene Franchise
    Novartis Pharma K.K., Japan
  • Akiko  Ikeda, RPh
    Akiko Ikeda, RPh Associate Director, Regulatory Development Dept.
    Janssen Pharmaceutical K.K., Japan

Digital Learning Catalog

DIA Learning: eLearning Soultions

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.